Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 2
2000 1
2012 3
2013 2
2014 3
2015 1
2016 2
2017 4
2018 5
2019 1
2020 4
2021 4
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Results by year
Filters applied: . Clear all
Page 1
Impact of Syndecan-2-Selected Mesenchymal Stromal Cells on the Early Onset of Diabetic Cardiomyopathy in Diabetic db/db Mice.
Pappritz K, Dong F, Miteva K, Kovacs A, El-Shafeey M, Kerim B, O'Flynn L, Elliman SJ, O'Brien T, Hamdani N, Tschöpe C, Van Linthout S. Pappritz K, et al. Among authors: o flynn l. Front Cardiovasc Med. 2021 May 21;8:632728. doi: 10.3389/fcvm.2021.632728. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34095245 Free PMC article.
MALDI-IMS as a Tool to Determine the Myocardial Response to Syndecan-2-Selected Mesenchymal Stromal Cell Application in an Experimental Model of Diabetic Cardiomyopathy.
Pappritz K, Klein O, Dong F, Hamdani N, Kovacs A, O'Flynn L, Elliman S, O'Brien T, Tschöpe C, Van Linthout S. Pappritz K, et al. Among authors: o flynn l. Proteomics Clin Appl. 2021 Jan;15(1):e2000050. doi: 10.1002/prca.202000050. Epub 2020 Dec 10. Proteomics Clin Appl. 2021. PMID: 33068073
Bliss MR, O'Flynn L, Sperring B. Bliss MR, et al. Among authors: o flynn l. J Wound Care. 1997 May 2;6(5):248-249. doi: 10.12968/jowc.1997.6.5.248. J Wound Care. 1997. PMID: 27937749
Immunogenicity of allogeneic mesenchymal stem cells.
Schu S, Nosov M, O'Flynn L, Shaw G, Treacy O, Barry F, Murphy M, O'Brien T, Ritter T. Schu S, et al. Among authors: o flynn l. J Cell Mol Med. 2012 Sep;16(9):2094-103. doi: 10.1111/j.1582-4934.2011.01509.x. J Cell Mol Med. 2012. PMID: 22151542 Free PMC article.
28 results